A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer. An Eastern Cooperative Oncology Group study (PZ586)

William J. Tester, Kyung Mann Kim, Robert L. Krigel, Philip D. Bonomi, John H. Glick, Robert F. Asbury, John M. Kirkwood, Ronald H. Blum, Joan H. Schiller